Received Feb 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | YZ9CY | IM / RA |
Patient reported experiencing fever, chills, hives, and myalgia approximately 48-72 hr after receiving a third Shingrix dose. Previous doses 1&2 of Shingrix were administered in 2022.